首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1685097

腎造口設備市場機會、成長動力、產業趨勢分析與預測 2025 - 2034

Nephrostomy Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年01月08日 | 出版商:

Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球腎造口設備市場價值為 13 億美元，預計在 2025 年至 2034 年期間將以 8.5% 的複合年成長率強勁成長。這一成長可歸因於腎臟相關疾病盛行率的上升，包括腎結石、泌尿道感染和腎積水。隨著越來越多的人尋求針對這些情況的醫療干預，對有效排水解決方案的需求持續激增。此外，人們越來越傾向於微創手術，這推動了腎臟造口設備的普及。腎造口技術的創新，例如引入先進的材料和設計，以提高精度和安全性，進一步推動了市場的成長。

這些技術進步也提高了程序的有效性，使其更加安全、更有效率。對患者安全性和精準度的日益關注，推動了旨在減少腎造口治療期間併發症的尖端設備的開發。隨著全球醫療保健體系的發展，對最先進的腎臟造口設備的需求將持續上升，進一步促進市場擴張。醫療保健基礎設施的不斷發展，包括升級的影像技術，也在推動整個市場的發展方面發揮關鍵作用。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	13億美元
預測值	29億美元
複合年成長率	8.5％

腎造口設備市場分為不同的產品類別，例如導引線、引流管、腎造口導管、鞘擴張器等。 2024 年，導絲部分創收 4.152 億美元，成為市場最大的貢獻者。導絲對於腎臟造口導管的準確放置至關重要，可在手術過程中提供靈活性和導航的便利性。親水性塗層等創新提高了它們的可操作性，減少了併發症並確保了患者獲得更好的治療效果。此外，針對特定患者群體（如兒科或老年患者）設計的專用導絲越來越受歡迎，促進了該領域的持續成長。

在應用方面，市場分為腎結石、泌尿道感染、膀胱癌和其他。其中，腎結石市場佔有最大佔有率，預計複合年成長率為 9.1%，到 2034 年達到 11 億美元。腎結石是尿路阻塞的主要原因，通常需要進行腎造口術才能有效引流。由於不良的飲食習慣、脫水和久坐的生活方式等因素，腎結石的發生率不斷上升，推動了對腎臟造口設備的需求。

在美國，腎造口設備市場規模在 2024 年達到 4.802 億美元，預計 2025 年至 2034 年的複合年成長率為 7.8%。美國仍然是最大的市場，這主要是由於腎臟相關疾病（尤其是腎結石）發生率高。該國還受益於發達的醫療保健基礎設施，其中包括可提高腎臟造口術成功率和精確度的先進成像技術。此外，主要市場參與者的存在和強勁的醫療保健支出進一步增強了美國市場的成長

產業生態系統分析
產業衝擊力
- 成長動力
  - 腎臟疾病盛行率上升
  - 微創手術的採用率提高
  - 腎臟造口設備的技術進步
  - 提高民眾意識
- 產業陷阱與挑戰
  - 與腎臟造口裝置相關的風險
  - 替代程序的可用性
成長潛力分析
2024 年定價分析
報銷場景
監管格局
技術格局
差距分析
波特的分析
PESTEL 分析
未來市場趨勢
價值鏈分析

第4章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
策略儀表板

第 5 章：市場估計與預測：按產品，2021 年至 2034 年

主要趨勢
導絲
引流管
腎造口導管
鞘管擴張器
其他產品

第 6 章：市場估計與預測：按應用，2021 年至 2034 年

主要趨勢
腎結石
泌尿道感染
膀胱癌
其他應用

第 7 章：市場估計與預測：按病患類型，2021 – 2034 年

主要趨勢
成人
兒科

第 8 章：市場估計與預測：依最終用途，2021 年至 2034 年

主要趨勢
醫院
診所
門診手術中心
其他最終用戶

第 9 章：市場估計與預測：按地區，2021 年至 2034 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第10章：公司簡介

angiodynamics
B. Braun
BD
Boston Scientific
CardinalHealth
Coloplast
Cook
Envaste
meditech
NeoMedical
OLYMPUS
rocamed
Teleflex
Uresil

簡介目錄

Product Code: 4325

The Global Nephrostomy Devices Market was valued at USD 1.3 billion in 2024 and is set to experience robust growth at a CAGR of 8.5% from 2025 to 2034. This growth can be attributed to a rising prevalence of kidney-related conditions, including kidney stones, urinary tract infections, and hydronephrosis. As more individuals seek medical intervention for these conditions, the demand for effective drainage solutions continues to surge. Additionally, there is a growing shift toward minimally invasive procedures, which is driving the increased adoption of nephrostomy devices. Innovations in nephrostomy technology, such as the introduction of advanced materials and designs that offer improved precision and safety, are further fueling market growth.

These technological advancements are also enhancing the effectiveness of procedures, making them safer and more efficient. The increased focus on patient safety and precision is propelling the development of cutting-edge devices aimed at reducing complications during nephrostomy treatments. As healthcare systems across the globe evolve, the demand for state-of-the-art nephrostomy devices will continue to rise, further promoting market expansion. The ongoing evolution of healthcare infrastructure, including upgraded imaging technologies, is also playing a key role in boosting the overall market.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$1.3 Billion
Forecast Value	$2.9 Billion
CAGR	8.5%

The nephrostomy devices market is segmented into various product categories, such as guidewires, drainage tubes, nephrostomy catheters, sheath dilators, and others. In 2024, the guidewires segment generated USD 415.2 million, making it the largest contributor to the market. Guidewires are crucial for the accurate placement of nephrostomy catheters, offering flexibility and ease of navigation during procedures. Innovations like hydrophilic coatings have improved their maneuverability, reducing complications and ensuring better outcomes for patients. Additionally, specialized guidewires designed for specific patient demographics, such as pediatric or elderly patients, are gaining traction, contributing to the segment's continued growth.

On the application side, the market is divided into kidney stones, urinary tract infections, bladder cancer, and others. Among these, the kidney stones segment holds the largest share and is expected to grow at a CAGR of 9.1%, reaching USD 1.1 billion by 2034. Kidney stones are a leading cause of urinary blockages, often requiring nephrostomy procedures for effective drainage. The increasing incidence of nephrolithiasis, driven by factors such as poor dietary habits, dehydration, and sedentary lifestyles, is propelling the demand for nephrostomy devices.

In the U.S., the nephrostomy devices market reached USD 480.2 million in 2024 and is projected to grow at a CAGR of 7.8% from 2025 to 2034. The U.S. remains the largest market, driven by a high incidence of kidney-related disorders, particularly kidney stones. The country also benefits from a well-developed healthcare infrastructure, which includes advanced imaging technologies that enhance the success and precision of nephrostomy procedures. Moreover, the presence of leading market players and strong healthcare spending further reinforces the market's growth in the U.S.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of kidney disorders
  - 3.2.1.2 Increased adoption of minimally invasive surgical procedure
  - 3.2.1.3 Technological advancements in nephrostomy devices
  - 3.2.1.4 Increasing awareness among population
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Risks associated with the nephrostomy devices
  - 3.2.2.2 Availability of substitute procedures
3.3 Growth potential analysis
3.4 Pricing analysis, 2024
3.5 Reimbursement scenario
3.6 Regulatory landscape
3.7 Technology landscape
3.8 Gap analysis
3.9 Porter's analysis
3.10 PESTEL analysis
3.11 Future market trends
3.12 Value chain analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

5.1 Key trends
5.2 Guidewires
5.3 Drainage tubes
5.4 Nephrostomy catheters
5.5 Sheath dilators
5.6 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

6.1 Key trends
6.2 Kidney stones
6.3 Urinary tract infections
6.4 Bladder cancer
6.5 Other applications

Chapter 7 Market Estimates and Forecast, By Patient Type, 2021 – 2034 ($ Mn)

7.1 Key trends
7.2 Adult
7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Clinics
8.4 Ambulatory surgical centers
8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE